What is the recommended treatment for back pain in a patient with Ehlers‑Danlos syndrome?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 11, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment of Back Pain in Ehlers-Danlos Syndrome

For back pain in Ehlers-Danlos syndrome, prioritize physical therapy with individualized, supervised exercise programs focused on joint stabilization and strengthening, as this is the only treatment proven effective for reducing joint instability and generalized pain in hypermobile EDS. 1

Understanding the Challenge

Ehlers-Danlos syndrome (EDS) is a heterogeneous group of inherited connective tissue disorders characterized by joint hypermobility, tissue fragility, and chronic pain. 2 The hypermobile type (hEDS) is the most common subtype, where chronic pain—including back pain—constitutes one of the main symptoms. 1 Unlike typical mechanical back pain, EDS-related back pain stems from underlying collagen abnormalities affecting joint stability and connective tissue integrity. 3, 2

First-Line Treatment: Physical Therapy

  • Supervised, individualized exercise therapy is the cornerstone of treatment for EDS-related back pain, as it directly addresses joint instability and prevents secondary osteoarthritis. 1

  • Exercise programs should incorporate individual tailoring, supervision, stretching, and strengthening—these components are associated with the best outcomes in chronic back pain. 4

  • Physical therapy should focus specifically on joint stabilization exercises to compensate for the underlying ligamentous laxity characteristic of EDS. 1

  • Home exercise programs improve function in the short term, but supervised group therapy provides better patient global assessment outcomes. 4

Pharmacologic Management

NSAIDs as First-Line Medication

  • NSAIDs are recommended as first-line pharmacologic treatment for pain and stiffness, with proven efficacy for spinal pain and function improvement. 4

  • For patients with gastrointestinal risk factors, use either non-selective NSAIDs plus gastroprotective agents or selective COX-2 inhibitors. 4

  • Consider cardiovascular risk factors when selecting between traditional NSAIDs and COX-2 inhibitors. 4

Adjunctive Medications

  • Acetaminophen may be considered for pain control when NSAIDs are insufficient, contraindicated, or poorly tolerated. 4

  • Tricyclic antidepressants or SNRIs (such as duloxetine) can be added for chronic pain management, particularly if neuropathic pain components are present. 4

  • Gabapentin may provide benefit if radicular symptoms develop, though evidence is limited to small, short-term benefits. 4

  • Avoid systemic corticosteroids, as they have not been shown more effective than placebo for back pain. 4

Nonpharmacologic Therapies for Refractory Pain

If pain persists despite physical therapy and NSAIDs, consider adding:

  • Acupuncture for chronic back pain (moderate evidence of effectiveness). 4, 5

  • Massage therapy for symptom relief in chronic cases. 4, 5

  • Cognitive-behavioral therapy to address pain catastrophizing and improve functional outcomes. 4

  • Spinal manipulation by appropriately trained providers may provide small to moderate benefits. 4, 5

  • Intensive interdisciplinary rehabilitation for patients not responding to initial therapies. 4

Critical Pitfalls to Avoid

  • Never recommend bed rest—remaining active is superior for back pain management in all contexts. 5

  • Avoid invasive interventional procedures (including nerve stimulation, epidural injections) for nonspecific back pain in EDS, as these lack evidence and carry additional risks given tissue fragility. 6

  • Exercise caution with any surgical intervention in EDS patients due to tissue fragility, abnormal wound healing, and increased surgical complications. 7, 3, 2

  • Arteriography is contraindicated in vascular EDS due to arterial fragility. 7

  • Do not overlook psychosocial factors, which are stronger predictors of back pain outcomes than physical examination findings. 5

When to Consider Imaging

  • Imaging is generally not indicated for nonspecific back pain in EDS unless red flags are present (cauda equina symptoms, progressive neurologic deficits, unexplained weight loss, fever). 8

  • If imaging becomes necessary after 4-6 weeks of failed conservative management with worsening symptoms, MRI is the preferred modality to visualize disc pathology and nerve root compression. 8

Treatment Algorithm

  1. Initiate supervised physical therapy with joint stabilization focus immediately. 1

  2. Start NSAIDs (with gastroprotection if indicated) for pain control. 4

  3. Add acetaminophen if NSAIDs are insufficient or contraindicated. 4

  4. After 4-8 weeks, if inadequate response, add cognitive-behavioral therapy, acupuncture, or massage therapy. 4, 5

  5. Consider tricyclic antidepressants or duloxetine for persistent chronic pain. 4

  6. For refractory cases, refer to intensive interdisciplinary rehabilitation program. 4

  7. Avoid opioids unless absolutely necessary, and only after exhausting all other options, given the chronic nature of EDS and risks of long-term opioid therapy. 4

References

Research

The Ehlers-Danlos syndromes.

Nature reviews. Disease primers, 2020

Research

Clinical and genetic aspects of Ehlers-Danlos syndrome, classic type.

Genetics in medicine : official journal of the American College of Medical Genetics, 2010

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Prognosis and Treatment of Sciatica Based on Pain Distribution

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Peripheral Nerve Stimulation for Nonspecific Chronic Low Back Pain

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

The vascular Ehlers-Danlos syndrome.

Current treatment options in cardiovascular medicine, 2006

Guideline

Imaging for Subacute Low Back Pain

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.